Ann L. Lee - 31 Mar 2023 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Chief Technical Officer
Signature
/s/ Gabriela Morales-Rivera, attorney-in-fact
Issuer symbol
PRME
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:22:29 UTC
Previous filing
19 Oct 2022
Next filing
23 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +180,995 $0.000000 180,995 31 Mar 2023 Common Stock 180,995 $12.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.